Minimally Invasive BPH Relief: Comparing UroLift® Implants to Traditional TURP

Benign Prostatic Hyperplasia (BPH)—the non-cancerous enlargement of the prostate gland—affects more than half of men in their 60s and up to 90% of men over 80. As the transition zone of the prostate expands, it compresses the prostatic urethra, causing lower urinary tract symptoms (LUTS) such as weak urinary stream, frequent nighttime urination (nocturia), hesitancy, and sudden urinary urgency.

When daily medications such as alpha-blockers and 5-alpha reductase inhibitors fail to provide adequate relief or cause unwanted side effects (including orthostatic hypotension, fatigue, and sexual dysfunction), surgical intervention becomes necessary. For decades, the undisputed gold standard for surgical clearance was Transurethral Resection of the Prostate (TURP). While effective at opening the urinary channel, TURP is an ablative, tissue-cutting operation associated with bleeding risks, hospital stays, catheter dependency, and high rates of sexual side effects—chief among them retrograde ejaculation.

To address these quality-of-life concerns, modern urology introduced the UroLift® System, a minimally invasive mechanical approach known as a Prostatic Urethral Lift (PUL). Rather than cutting, heating, or removing prostate tissue, UroLift uses permanent micro-implants to retract the encroaching lateral lobes, immediately opening the obstructed urethra while preserving sexual and ejaculatory function.

In South Florida, Dr. Mourad Abouelleil is a board-certified urologist with the Palm Beach Health Network Physician Group, practicing at Good Samaritan Medical Center in West Palm Beach and Palm Beach Gardens Medical Center. Having completed his medical education at the University of Wisconsin and comprehensive urology residency training at SUNY Upstate Medical University in Syracuse, New York, Dr. Abouelleil specializes in both resective and non-resective treatments for BPH. By tailoring treatment to prostate volume, lobe morphology, and lifestyle goals, Dr. Abouelleil helps men achieve durable urinary relief while protecting functional quality of life.

The Mechanism: Mechanical Retraction vs. Surgical Tissue Resection

The fundamental difference between the two procedures lies in how they address urethral obstruction:

• The UroLift® Approach (Mechanical Suture Suspension): Under cystoscopic visualization, a slender delivery device passes through the natural urinary channel. Small permanent implants—consisting of a nitinol capsular tab, a PET suture, and a stainless steel urethral end-piece—are deployed transprostatically. The implants draw the obstructive prostatic tissue laterally toward the outer capsule, acting like window curtain tie-backs to widen the anterior urethral lumen. Because no tissue is burned, vaporized, or excised, there is no raw wound bed or deep thermal injury.
• The Traditional TURP Approach (Electrosurgical Cavitation): A rigid resectoscope equipped with a wire loop is inserted through the urethra. Using monopolar or bipolar high-frequency electrical current, the surgeon systematically chips away the enlarged transition zone tissue piece by piece. The resulting cavity is thoroughly irrigated, and the resected prostate fragments are evacuated from the bladder. The raw prostatic cavity must then re-epithelialize over several weeks.

Preserving Sexual Function: The Ejaculatory Advantage

The most notable difference between UroLift and TURP is their impact on male sexual function:

Retrograde Ejaculation (“Dry Orgasm”)

Normal ejaculation requires an intact bladder neck (internal sphincter) to seal tightly during orgasm, directing semen forward through the penile urethra.

• In a traditional TURP, electrosurgical resection disrupts the internal bladder neck sphincter mechanism. Consequently, 65% to 75% of men experience permanent retrograde ejaculation, where seminal fluid flows backward into the bladder rather than exiting the penis.
• Because the UroLift protocol does not cut or ablate the bladder neck or the verumontanum, it carries a 0% rate of de novo sustained retrograde ejaculation or erectile dysfunction in clinical trials. Orgasm sensation and forward antegrade ejaculation remain intact.

Erectile Function

TURP carries a small but documented risk of erectile dysfunction (typically 3% to 5%) due to lateral thermal energy conduction to the adjacent cavernous nerves located just outside the prostatic capsule. UroLift uses zero thermal energy, avoiding nerve-stun injuries entirely.

Comparative Overview: UroLift® System vs. Traditional TURP

Patient Candidacy: Selecting the Right Procedure

Determining whether a patient is a candidate for UroLift or better served by an ablative procedure like TURP depends heavily on anatomical dimensions assessed via transrectal ultrasound (TRUS) or office cystoscopy:

Ideal Candidates for UroLift:

• Men with small-to-moderate prostate enlargement (prostate volumes between 30 and 80–100 cc).
• Men prioritizing the preservation of sexual vitality, normal ejaculation, and fertility.
• Patients who cannot safely discontinue blood thinners (anticoagulants or antiplatelet agents) for major surgery.
• Men seeking a rapid return to work and physical activity without prolonged catheterization.
• Lateral lobe obstruction without a dominant obstructive middle lobe.

When Traditional TURP or Enucleation is Preferred:

• Very Large Prostates ($> 100\text{ cc}$): Excessively enlarged glands often require formal tissue debulking (TURP, Holmium Laser Enucleation [HoLEP], or robotic simple prostatectomy) to achieve long-term channel clearance.
• Large Obstructive Intravesical Median Lobes: When an isolated middle lobe ball-valves into the bladder neck, a formal resection or specialized median-lobe lift technique is required.
• Severe Urinary Retention with Bladder Atony: Men whose bladders have lost contractile strength (detrusor underactivity) often require wide channel cavitation to facilitate passive bladder emptying.

Recovery Experience: What Patients Can Expect

The differences in tissue trauma between the two approaches directly affect the post-procedure recovery experience:

• Post-UroLift Course: The procedure takes 15 to 30 minutes. Most patients void independently in recovery and return home without a catheter. Mild dysuria (burning with urination), light hematuria (pink-tinged urine), and pelvic fullness are common for several days as the prostate adjusts to the implants, but these symptoms typically resolve within 1 to 2 weeks. Most men resume normal non-strenuous routines within 48 to 72 hours.
• Post-TURP Course: Patients require continuous bladder irrigation (CBI) through a heavy three-way catheter in the immediate postoperative period to prevent blood clots from blocking the bladder. The catheter remains in place for 24 to 72 hours. Strenuous exercise, heavy lifting, and sexual activity are restricted for four to six weeks while the large internal wound bed heals.

Conclusion & Practice Information

Relief from an enlarged prostate no longer requires accepting permanent sexual side effects or weeks of recovery. By evaluating prostate volume, median lobe architecture, and patient priorities, Dr. Mourad Abouelleil provides personalized BPH care—offering the minimally invasive UroLift System for men seeking rapid relief and preserved function, alongside definitive electrosurgical resection when anatomy requires broader tissue clearance.

• Surgeon: Dr. Mourad Abouelleil, MD
• Board Certification: American Board of Urology
• Practice Group: Urology Medical Associates – Palm Beach Health Network Physician Group
• Hospital Affiliations: Good Samaritan Medical Center (West Palm Beach) & Palm Beach Gardens Medical Center
• Primary Office Locations:
  • West Palm Beach: 1411 North Flagler Drive, Suite 3800, West Palm Beach, FL 33401
  • Jupiter: 641 University Boulevard, Suite 105, Jupiter, FL 33458
  • Port St. Lucie: 900 Southeast Becker Road, Port St. Lucie, FL 34984
• Office Consultations: (561) 291-7182